Potential concerns regarding the use of sex-specific cutpoints for high-sensitivity troponin assays: counterpoint

There are biological differences between males and females in cardiac structure and function that have been recently revealed using sensitive imaging techniques such as magnetic resonance tomography (1). With the availability of more sensitive assays capable of measuring extremely low concentrations...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Giannitsis, Evangelos (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2017
In: Clinical chemistry
Year: 2016, Jahrgang: 63, Heft: 1, Pages: 264-266
ISSN:1530-8561
DOI:10.1373/clinchem.2016.254680
Online-Zugang:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1373/clinchem.2016.254680
Verlag, kostenfrei, Volltext: http://clinchem.aaccjnls.org/content/63/1/264
Volltext
Verfasserangaben:Evangelos Giannitsis

MARC

LEADER 00000caa a2200000 c 4500
001 1576182347
003 DE-627
005 20220814155750.0
007 cr uuu---uuuuu
008 180608r20172016xx |||||o 00| ||eng c
024 7 |a 10.1373/clinchem.2016.254680  |2 doi 
035 |a (DE-627)1576182347 
035 |a (DE-576)506182347 
035 |a (DE-599)BSZ506182347 
035 |a (OCoLC)1341011140 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Giannitsis, Evangelos  |e VerfasserIn  |0 (DE-588)113336241  |0 (DE-627)577184091  |0 (DE-576)289759579  |4 aut 
245 1 0 |a Potential concerns regarding the use of sex-specific cutpoints for high-sensitivity troponin assays  |b counterpoint  |c Evangelos Giannitsis 
246 3 3 |a Counterpoint: Potential concerns regarding the use of sex-specific cutpoints for high-sensitivity troponin assays 
264 1 |c 2017 
300 |a 3 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published online December 30, 2016 
500 |a Gesehen am 08.06.2018 
520 |a There are biological differences between males and females in cardiac structure and function that have been recently revealed using sensitive imaging techniques such as magnetic resonance tomography (1). With the availability of more sensitive assays capable of measuring extremely low concentrations of cardiac troponin, such biological differences may contribute to 99th percentile reference values for cardiac troponin that have been found to be lower in women than in men (2). Although it is still unclear whether clinical evidence is strong enough to support the use of sex-specific cutoffs in clinical practice, the Joint ESC/ACCF/AHA/WHF (European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation) Task Force for the Universal Definition of Myocardial Infarction already recommends the use of sex-specific cutoffs (3). However, there are several reasons to question such a general recommendation including a lack of consistent clinical evidence, the need to validate such criteria for each high-sensitivity (hs)2 cardiac troponin assay owing to potential analytical differences between assays, and the wide variation in 99th percentile values across commercially available cardiac troponin assays (4). These issues may confuse clinicians and translate into the incorrect incorporation of such limits into clinical routine as diagnostic algorithms become increasingly complicated.In particular, there are 5 relevant concerns that argue against such a recommendation and that require more elaboration.1. Clinical evidence supporting the use of sex-specific cutoffs is sparse and controversial. Application of sex-specific 99th percentile values (4) was reported to increase numbers of non-ST elevation myocardial infarctions (NSTEMIs) by 4.7%-11% in females depending on the hs-cardiac troponin assay used, but also to decrease numbers of NSTEMIs in males by 2%-3% (5-7). Whether diagnostic reclassification translates into improved prediction of … 
534 |c 2016 
773 0 8 |i Enthalten in  |t Clinical chemistry  |d Washington, DC : American Association for Clinical Chemistry, 1955  |g 63(2017), 1, Seite 264-266  |h Online-Ressource  |w (DE-627)266883117  |w (DE-600)1468161-4  |w (DE-576)075146401  |x 1530-8561  |7 nnas  |a Potential concerns regarding the use of sex-specific cutpoints for high-sensitivity troponin assays counterpoint 
773 1 8 |g volume:63  |g year:2017  |g number:1  |g pages:264-266  |g extent:3  |a Potential concerns regarding the use of sex-specific cutpoints for high-sensitivity troponin assays counterpoint 
856 4 0 |u http://dx.doi.org/10.1373/clinchem.2016.254680  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://clinchem.aaccjnls.org/content/63/1/264  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20180608 
993 |a Article 
994 |a 2017 
998 |g 113336241  |a Giannitsis, Evangelos  |m 113336241:Giannitsis, Evangelos  |d 910000  |d 910100  |e 910000PG113336241  |e 910100PG113336241  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j  |y j 
999 |a KXP-PPN1576182347  |e 3012224238 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"corporate":[{"role":"isb","display":"American Association of Clinical Chemists"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Potential concerns regarding the use of sex-specific cutpoints for high-sensitivity troponin assays counterpointClinical chemistry","note":["Gesehen am 26.08.2021"],"pubHistory":["1.1955 -"],"language":["eng"],"part":{"text":"63(2017), 1, Seite 264-266","pages":"264-266","extent":"3","issue":"1","year":"2017","volume":"63"},"origin":[{"dateIssuedKey":"1955","publisherPlace":"Washington, DC ; Oxford","publisher":"American Association for Clinical Chemistry ; Oxford University Press","dateIssuedDisp":"1955-"}],"title":[{"title_sort":"Clinical chemistry","subtitle":"journal of the American Association for Clinical Chemistry ; international journal of laboratory medicine and molecular diagnostics","title":"Clinical chemistry"}],"id":{"zdb":["1468161-4"],"issn":["1530-8561"],"eki":["266883117"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"266883117"}],"origin":[{"dateIssuedDisp":"2017","dateIssuedKey":"2017"}],"title":[{"title":"Potential concerns regarding the use of sex-specific cutpoints for high-sensitivity troponin assays","subtitle":"counterpoint","title_sort":"Potential concerns regarding the use of sex-specific cutpoints for high-sensitivity troponin assays"}],"id":{"doi":["10.1373/clinchem.2016.254680"],"eki":["1576182347"]},"physDesc":[{"extent":"3 S."}],"person":[{"family":"Giannitsis","role":"aut","given":"Evangelos","display":"Giannitsis, Evangelos"}],"recId":"1576182347","name":{"displayForm":["Evangelos Giannitsis"]},"titleAlt":[{"title":"Counterpoint: Potential concerns regarding the use of sex-specific cutpoints for high-sensitivity troponin assays"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Published online December 30, 2016","Gesehen am 08.06.2018"],"language":["eng"]} 
SRT |a GIANNITSISPOTENTIALC2017